✦ LIBER ✦

How relevant is the experience of the urologist in transrectal ultrasound for an accurate preoperative staging of prostate cancer?

✍ Scribed by A. Bannowsky; A. Probst; L. Bäurle; T. Loch

Book ID: 113734479
Publisher: Dougmar Publishing Group, Inc.
Year: 2009
Tongue: English
Weight: 93 KB
Volume: 6
Category: Article
ISSN: 1875-6867
DOI: 10.1016/j.jomh.2009.08.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

22 TRANSRECTAL ULTRASOUND (TRUS) IN PREO

22 TRANSRECTAL ULTRASOUND (TRUS) IN PREOPERATIVE STAGING OF PROSTATE CANCER IN COMPARISON TO THE EXPERIENCE OF THE UROLOGIST

✍ A. Bannowsky; A.C. Loch; L. Bäurle; T. Loch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 505 KB

The role of transrectal ultrasound-guide

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy gleason score in prediction of final pathologic diagnosis in prostate cancer

✍ Perinchery Narayan; Viswanathan Gajendran; Stephen P. Taylor; Ashutosh Tewari; J 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 867 KB

2019 CONTRAST ENHANCED ULTRASOUND FOR TH

2019 CONTRAST ENHANCED ULTRASOUND FOR THE DETECTION OF PROSTATE CANCER: DO TARGETED BIOPSIES RESULT IN MORE ACCURATE CLINICAL STAGING?

✍ Kelly, Douglas; Jackson, Jessica; Mark, James; Halpern, Ethan; Forsberg, Flemmin 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

Scientific Presentation Award: The combi

Scientific Presentation Award: The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients

✍ Norton, L.E.; Giuliano, A.E. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB